Thank you, Madam Chair. I would address my question to Dr. Nguyen.
You just mentioned during your testimony that AMR is as critical as HIV and other life-threatening diseases. I think that also resonates with the concern that Dr. Bettina Hamelin raised the other day when she was saying that AMR is a present threat. It's not something we can leave to the future.
My question for you is this: How satisfied are you with the current funding that is available for AMR research in Canada when it comes to the development of medicine and its availability and marketability to Canada and Canadians?
